The evolution of resistance to traditional platinum-based anticancer drugs has compelled
researchers to investigate the cytostatic properties of alternative transition metal-based …

The structural features of copper (II), nickel (II), cobalt (II) and zinc (II) complexes with the
antimicrobial drugs quinolones and non-steroidal anti-inflammatory drugs (NSAIDs) as …

Herein, three new mixed-ligand complexes were synthesized through the reaction of Fe (III),
Ni (II) and Cu (II) with moxifloxacin (MOX) in the presence of tri-substituted imidazole (TSI) to …

Copper (II) complexes with the non-steroidal anti-inflammatory drugs (NSAIDs) naproxen
and diclofenac have been synthesized and characterized in the presence of nitrogen donor …

A series of divalent and one trivalent metal chelates of the azo ligand resulting from coupling
of sulfafurazole diazonium chloride with resorcinol have been designed and synthesized …

Copper (II) complexes with the non-steroidal antiinflammatory drug mefenamic acid in the
presence of aqua or nitrogen donor heterocyclic ligands (2, 2′-bipyridine, 1, 10 …

Inorganic complexes are versatile platforms for the development of potent and selective
pharmaceutical agents. Cobalt possesses a diverse array of properties that can be …

Over the past few decades, the realm of inorganic medicinal chemistry has been dominated
by the study of the anti-cancer properties of transition metal complexes, particularly those …

Zinc complexes with the third-generation quinolone antibacterial drugs levofloxacin and
sparfloxacin have been synthesized and characterized. The deprotonated quinolones act as …

Copper (II) complexes with the non-steroidal antiinflammatory drug flufenamic acid (Hfluf) in
the presence of N, N-dimethylformamide (DMF) or nitrogen donor heterocyclic ligands (2 …